Protective effects of puerarin against 1-methyl-4-phenylpyridinium-induced mitochondrial apoptotic death in differentiated SH-SY5Y cells

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 9, 2011, Pages 1222-1226

  Cheng, Yuefa ^a   Zhu, Guoqi ^b   Guan, Yali ^a   Liu, Yingshuo ^a   Hu, Yan ^a   Li, Qinglin ^b  

^a HEBEI UNITED UNIVERSITY   (China)

^b ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Mitochondria; Parkinson's disease; Puerarin

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; PUERARIN;

APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL PROTECTION; CELL STRAIN; CELL VIABILITY; DEGENERATIVE DISEASE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRION; NEUROPROTECTION; WESTERN BLOTTING;

1-METHYL-4-PHENYLPYRIDINIUM; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 8; CASPASE 9; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; ISOFLAVONES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA;

EID: 80051524339     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20110924     Document Type: Article

References (13)

1. Bekris L M, Mata I F, Zabetian C P. The genetics of Parkinson disease[J]. J Geriatr Psychiatry Neurol, 2010,23(4):228.
2. +-elicited apoptosis[J]. Neurosci Res, 2009,63(1):52.
3. Zhu G Q, Wang X C, Chen Y F, et al. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease[J]. Planta Med, 2010,76:1820.
4. Orth M, Schapira A H. Mitochondrial involvement in Parkinson's disease[J]. Neurochem Int, 2002,40(6):533.
5. Schapira A H. Complex I: inhibitors, inhibition and neurodegeneration[J]. Exp Neurol, 2010,224(2):331.
6. Janetzky B, Hauck S, Youdim M B, et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease[J]. Neurosci Lett, 1994,169:126.
7. Hamre K, Tharp R, Poon K, et al. Differential strain susceptibility following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus[J]. Brain Res, 1999,828(1/2):91.
8. Alam Z I, Daniel S E, Lees A J, et al. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease[J]. J Neurochem, 1997,69:1326.
9. Viswanath V, Wu Y, Boonplueang R, et al. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease[J]. J Neurosci, 2001,21(24):9519.
10. Jiang B, Liu J H, Bao M L, et al. Hydrogen peroxide-induced apoptosis in pc12 cells and the protective effect of puerarin[J]. Cell Biol Int, 2003,27(12):1025.
11. +-induced neurotoxicity in PC12 cells mediated by inhibiting mitochondrial dysfunction and caspase-3-like activation[J]. Neurosci Res, 2005,53(2):183.